Clinical evaluation of the Nanoduct sweat test system in the diagnosis of cystic fibrosis after newborn screening

European Journal of Pediatrics

Volumn 174, Issue 8, 2015, Pages 1025-1034

  Langen, Annette Vernooij van ^a   Dompeling, Edward ^b   Yntema, Jan Bart ^c   Arets, Bert ^d   Tiddens, Harm ^e   Loeber, Gerard ^f   Dankert Roelse, Jeannette ^g  

^a ST JANSDAL HOSPITAL   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^f NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^g Zuyderland Medical Centre   (Netherlands)

Author keywords

Cystic fibrosis; Diagnosis; Infants; Nanoduct; Sweat test

Indexed keywords

CHLORIDE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; NANOTUBE;

ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONDUCTANCE; CONTROLLED STUDY; COULOMETRY; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; GOLD STANDARD; HUMAN; INFANT; INTERMETHOD COMPARISON; METABOLIC SYNDROME X; NEWBORN; NEWBORN SCREENING; PRIORITY JOURNAL; SWEAT TEST; CHEMISTRY; CLINICAL CHEMISTRY; COMPARATIVE STUDY; DEVICES; FEMALE; MALE; NANOTECHNOLOGY; PROCEDURES; SWEAT;

CHLORIDES; CLINICAL CHEMISTRY TESTS; CYSTIC FIBROSIS; FEMALE; HUMANS; INFANT, NEWBORN; MALE; NANOTECHNOLOGY; NANOTUBES; NEONATAL SCREENING; SWEAT;

EID: 84938288226     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-015-2501-0     Document Type: Article

References (26)

1. Barben J, Ammann RA, Metlagel A, Schoeni MH (2005) Conductivity determined by a new sweat analyzer compared with chloride concentrations for the diagnosis of cystic fibrosis. J Pediatr 146:183–188
2. Barben J, Rüegg CS, Gallatti S, Kuehni CE, Baumgartner M, Torresani T, Schöni M (2013) Comparison of two sweat test systems (Macroduct versus Nanoduct) for the diagnosis of cystic fibrosis in the newborn screening program in Switzerland. J Cyst Fibros 12(Abstract 37):S57
3. De Boeck K, Wilschanski M, Castellani C, Taylor C, Cuppens H, Dodge JA, Sinaasappel M (2006) Cystic fibrosis: terminology and diagnostic algorithms. Thorax 61:627–635
4. Desax MC, Ammann RA, Hammer J, Schoeni MH, Barben J (2007) Nanoduct(R) sweat testing for rapid diagnosis in newborns, infants and children with cystic fibrosis. Eur J Pediatr
5. Eng W, LeGrys VA, Schechter MS, Laughon MM, Barker PM (2005) Sweat-testing in preterm and full-term infants less than 6 weeks of age. Pediatr Pulmonol 40:64–67
6. Farrell PM, Koscik RE (1996) Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis. Pediatrics 97:524–528
7. Funk MJ, LeGrys VA (2005) Testing diagnostic tests: why size matters. J Pediatr 146:159–162
8. Hammond KB, Turcios NL, Gibson LE (1994) Clinical evaluation of the macroduct sweat collection system and conductivity analyzer in the diagnosis of cystic fibrosis. J Pediatr 124:255–260
9. Heeley ME (2000) Indirect measurements of sweat electrolyte concentration in the laboratory diagnosis of cystic fibrosis. Arch Dis Child 82:420–424
10. Kleyn M, Korzeniewski S, Grigorescu V, Young W, Homnick D, Goldstein-Filbrun A, Schuen J, Nasr S. Predictors of insufficient sweat production during confirmatory testing for cystic fibrosis. Pediatr Pulmonol;46:23–30
11. LeGrys VA (2001) Assessment of sweat-testing practices for the diagnosis of cystic fibrosis. Arch Pathol Lab Med 125:1420–1424
12. LeGrys VA, Rosenstein BJ, Doumas BT, Miller WG, D’Orazio P, Eckfeld JH, Evans SA, Graham GA, Myers GL, Parsons PJ, Stanton NV (2000) Sweat Testing: Sample Collection and Quantative Analysis; Approved Guideline-Second Edition. NCCLS;20
13. Lezana JL, Vargas MH, Karam-Bechara J, Aldana RS, Furuya ME (2003) Sweat conductivity and chloride titration for cystic fibrosis diagnosis in 3834 subjects. J Cyst Fibros 2:1–7
14. Losty HC (2006) The evaluation of a novel conductometric device for the diagnosis of cystic fibrosis. Ann Clin Biochem 43:375–381
15. Mastella G, Di Cesare G, Borruso A, Menin L, Zanolla L (2000) Reliability of sweat-testing by the Macroduct collection method combined with conductivity analysis in comparison with the classic Gibson and Cooke technique. Acta Paediatr 89:933–937
16. Mayell SJ, Munck A, Craig JV, Sermet I, Brownlee KG, Schwarz MJ, Castellani C, Southern KW (2009) A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis. J Cyst Fibros 8:71–78
17. Moran J, Quirk K, Duff AJ, Brownlee KG (2007) Newborn screening for CF in a regional paediatric centre: the psychosocial effects of false-positive IRT results on parents. J Cyst Fibros 6:250–254
18. Parad RB, Comeau AM, Dorkin HL, Dovey M, Gerstle R, Martin T, O’Sullivan BP (2005) Sweat testing infants detected by cystic fibrosis newborn screening. J Pediatr 147:S69–72
19. Sands D, Oltarzewski M, Nowakowska A, Zybert K. Bilateral sweat tests with two different methods as a part of cystic fibrosis newborn screening (CF NBS) protocol and additional quality control. Folia Histochem Cytobiol 48:358–365
20. Sezer RG, Aydemir G, Akcan AB, Paketci C, Karaoglu A, Aydinoz S, Bozaykut A. Nanoduct sweat conductivity measurements in 2664 patients: relationship to age, arterial blood gas, serum electrolyte profiles and clinical diagnosis. J Clin Med Res5:34–41
21. Sims EJ, Clark A, McCormick J, Mehta G, Connett G, Mehta A (2007) Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy. Pediatrics 119:19–28
22. Slieker MG, Uiterwaal CS, Sinaasappel M, Heijerman HG, van der Laag J, van der Ent CK (2005) Birth prevalence and survival in cystic fibrosis: a national cohort study in The Netherlands. Chest 128:2309–2315
23. Tluczek A, Koscik RL, Farrell PM, Rock MJ (2005) Psychosocial risk associated with newborn screening for cystic fibrosis: parents’ experience while awaiting the sweat-test appointment. Pediatrics 115:1692–1703
24. Vernooij-van Langen AM, Loeber JG, Elvers B, Triepels RH, Gille JJ, Van der Ploeg CP, Reijntjens S, Dompeling E, Dankert-Roelse JE (2012) Novel strategies in newborn screening for cystic fibrosis: a prospective controlled study. Thorax 67:289–295
25. Williams SN, Nussbaum E, Chin TW, Do PC, Singh KE, Randhawa I (2014) Diagnosis of cystic fibrosis in the kindred of an infant with CFTR-related metabolic syndrome: importance of follow-up that includes monitoring sweat chloride concentrations over time. Pediatr Pulmonol 49:E103–108
26. www.STARD-statement.org. In; 2013